ZYME Zymeworks Inc.
Healthcare$25.40-0.82%ClosedMarket Cap: $1.87B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.01
P/S
23.19
EV/EBITDA
2025.69
DCF Value
$-18.31
FCF Yield
-2428.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
94.4%
Operating Margin
-140.4%
Net Margin
-126.3%
ROE
-0.2%
ROA
-0.0%
ROIC
-0.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.4M | -18.2% | $-47.1M | $-44.2M | $— | — |
| Q4 null | $2.5M | 32.8% | $-44.2M | $-41.2M | $— | — |
| FY null | $106.0M | 100.0% | $-92.5M | $-81.1M | $— | — |
| Q3 null | $27.6M | 100.0% | $-22.1M | $-19.6M | $— | — |
| Q2 null | $48.7M | 100.0% | $-674.0K | $2.3M | $— | — |
| Q1 null | $27.1M | 100.0% | $-25.6M | $-22.6M | $— | — |
| Q4 null | $31.0M | 100.0% | $-22.2M | $-23.5M | $— | — |
| FY null | $76.3M | 100.0% | $-137.1M | $-122.7M | $— | — |
| Q3 null | $16.0M | 100.0% | $-34.2M | $-29.9M | $— | — |
| Q2 null | $19.2M | 100.0% | $-42.9M | $-37.7M | $— | — |
| Q1 null | $10.0M | 100.0% | $-37.8M | $-31.7M | $— | — |
| Q4 2023 | $16.9M | 100.0% | $-23.4M | $-14.5M | $-0.20 | — |